Showing 3951-3960 of 10624 results for "".
The CONFIDENCE Trial: Data Insights
https://reachmd.com/cme/ERA-2025-nsMRA-CKM/the-confidence-trial-data-insights/35845/Dr. Hiddo Heerspink shares CONFIDENCE trial insights from ERA 2025 showing finerenone + empagliflozin lowers albuminuria in patients with CKD and T2D.Navigating the Modern PsA Treatment Landscape
https://reachmd.com/programs/living-rheum/navigating-the-modern-psa-treatment-landscape/51049/Reframing Sjögren’s Syndrome: Insights from a Comprehensive Review
https://reachmd.com/programs/living-rheum/reframing-sjogrens-syndrome-insights-from-a-comprehensive-review/36335/Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation in Locally Advanced HNSCC: First Results From the Randomized Phase 2b ADRISK Trial
https://reachmd.com/clinical-practice/oncology-hematology/adjuvant-pembrolizumab-plus-cisplatin-based-chemoradiation-in-locally-advanced-hnscc-first-results-from-the-randomized-phase-2b-adrisk-trial/39706/In the phase 2b ADRISK study, pembrolizumab added to adjuvant cisplatin-based chemoradiation did not significantly improve EFS or OS in locally advanced HNSCC.The Battle of Biostimulators: PLLA vs hyperdilute CaHA
https://reachmd.com/ma-issues-index/july-august-2025/biostimulators-PLLA-vs-HyperdiluteCaHA/36663/Key takeaways from Dr. Kay Durairaj's YoungMD Connect workshopEverest ER: Practicing Medicine at 17,000 Feet
https://reachmd.com/programs/clinicians-roundtable/everest-er-practicing-medicine-17000-feet/9692/Dr. Luanne Freer talks about the perils and triumphs of founding and operating a clinic at 17,000 feet.Combination Drug Treatment Reduces Agitation in Patients with Alzheimer's Disease
https://reachmd.com/programs/the-jama-report/combination-drug-treatment-reduces-agitation-patients-alzheimers-disease/7712/[Read the Article] Agitation is common in patients with dementia and can contribute to distress for patients and caregivers and an increased risk of institutionalization. Nonpharmacological interventions are recommended as first-line therapy, but many patients fail to respond, and medications are ofRethinking Anti-Aging
https://reachmd.com/topics/regenerative-medicine/rethinking-anti-aging/48724/Cellular longevity and the role of mTOR in skin health.Advancing Digital Medicine in Dermatology
https://reachmd.com/programs/practical-dermatology/advancing-digital-medicine-in-dermatology/18187/The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advancImproving Postsurgical Outcomes in Crohn’s Disease
https://reachmd.com/programs/gi-insights/improving-postsurgical-outcomes-in-crohns-disease/32327/Explore how prehabilitation programs and lifestyle changes can help improve postoperative recovery for patients with Crohn’s disease.